Press release
Staphylococcus Aureus Testing Market Detailed Analytical Overview by 2028 | Roche Diagnostics , STD Rapid Test Kits, Thermo Fisher Scientific Inc
For More Information, and to Download the Sample of This Report, please: https://www.futuremarketinsights.com/reports/sample/rep-gb-5284
Staphylococcus Aureus Testing Market: Drivers and Restraint
Growing incidence of Staph infections is the major factor driving the growth of global staphylococcus Aureus testing market. The inappropriate sanitary environment is the major cause for the spread of Staph infections. Staphylococcus Aureus screening is the mandatory screening test prior to taking insulin and growing awareness of bacterial infection across the globe is expected to push the market growth. Advanced rapid diagnostic tests availability also boost the growth of Staphylococcus Aureus Testing Market over the forecast period. However, inadequate reimbursement in developing the region and limited access to regular healthcare may be the restraints for the global staphylococcus Aureus testing market.
Staphylococcus Aureus testing Market: Segmentation
The global market for Staphylococcus Aureus testing segmented by product type, modality, material, end user, and region:
Segmented by Test Type
Coagulase Test
Ancillary Tests
Agar-Based Tests
Nucleic Acid Amplification Tests
Segmented by Application
Pharmaceutical
Clinical
Food Testing
Other
Segmented by End User
Hospitals
Diagnostic Clinics
Food Testing laboratories
Others
Segmented by Region
North America
Latin America
Western Europe
Eastern Europe
APEJ(Asia-Pacific Excluding Japan)
Japan
The Middle East and Africa
Staphylococcus Aureus testing Market: Overview
Huge competition in the market is due to the increased number of service providers. High efficiency and less price on the testing service are the factors for survival in the market. According to the SENTRY Antimicrobial Surveillance Program the prevalence of Staphylococcus Aureus related disease in North America (26.0%), Latin America ( 21.6%) and in Europe ( 19.5%).
By Test type, Staphylococcus Aureus testing can be segmented into Coagulase Test, Ancillary Tests, Agar-Based Tests and Nucleic Acid Amplification Tests
By Application, the global Staphylococcus Aureus testing market is segmented into Pharmaceutical, Clinical, food testing and other
By End-user, Staphylococcus Aureus testing can be segmented into Segmented into Hospitals, Diagnostic Clinics, Food Testing laboratories and others
By region, Staphylococcus Aureus testing market is segmented into North America, Western Europe, Eastern Europe, Latin America, Asia-Pacific excluding Japan, Japan and the Middle East and Africa
Staphylococcus Aureus testing Market: Region-wise Outlook
By region, global Staphylococcus Aureus testing market is segmented into seven key regions viz. North America, Latin America, Western Europe, Eastern Europe, APEJ (Asia-Pacific Excluding Japan), Japan and Middle East & Africa. North America followed by Europe will continue to dominate the global Staphylococcus Aureus testing market attributed to high incidence. Furthermore, the newly developed product in the Staphylococcus Aureus testing is also expected to result in higher demand for Staphylococcus Aureus testing market globally over the forecast period. Asia Pacific excluding Japan is expected to be the emerging region in the global Staphylococcus Aureus testing market.
Request to Browse Report Customization @ https://www.futuremarketinsights.com/toc/rep-gb-5284
Staphylococcus Aureus testing Market: Key Market Participants
The key players in the Staphylococcus Aureus testing market are Abbott Laboratories Inc., Siemens Healthcare GmbH, Bio Rad Laboratories Inc., Thermo Fisher Scientific Inc., Roche Diagnostics (H. Hoffman-La Roche Ltd.), STD Rapid Test Kits etc. among others.
About Us
Future Market Insights is the premier provider of market intelligence and consulting services, serving clients in over 150 countries. FMI is headquartered in London, the global financial capital, and has delivery centers in the U.S. and India.
FMI’s research and consulting services help businesses around the globe navigate the challenges in a rapidly evolving marketplace with confidence and clarity. Our customized and syndicated market research reports deliver actionable insights that drive sustainable growth. We continuously track emerging trends and events in a broad range of end industries to ensure our clients prepare for the evolving needs of their consumers.
Contact Us
U.S. Office
616 Corporate Way, Suite 2-9018,
Valley Cottage, NY 10989,
United States
T: +1-347-918-3531
F: +1-845-579-5705
Email: sales@futuremarketinsights.com
Web: https://www.futuremarketinsights.com/
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Staphylococcus Aureus Testing Market Detailed Analytical Overview by 2028 | Roche Diagnostics , STD Rapid Test Kits, Thermo Fisher Scientific Inc here
News-ID: 1499507 • Views: …
More Releases from Future Market Insights
Medical Nutrition Market Forecast 2026-2036: Market Size, Share, Competitive Lan …
The global Medical Nutrition Market is estimated to be valued at USD 17.2 billion in 2025 and is projected to reach USD 31.1 billion by 2035, registering a compound annual growth rate (CAGR) of 6.1% during the forecast period.
Explore trends before investing - request a sample report today! https://www.futuremarketinsights.com/reports/sample/rep-gb-19755
The medical nutrition market is witnessing robust growth, driven by an increasing focus on preventive healthcare and the rising prevalence of…
Parenteral Nutrition Market Report 2026-2036: High-Value Insights for Strategy, …
The global Parenteral Nutrition (PN) Market is entering a phase of sustained, clinically driven expansion as healthcare systems place stronger emphasis on nutritional intervention in critical and long-term care. Valued at USD 6.9 billion in 2025, the market is projected to nearly double to USD 12.9 billion by 2035, registering a CAGR of 6.5% over the forecast period. Growth is underpinned by rising chronic disease prevalence, higher rates of malnutrition,…
Comprehensive Analysis of the Collagen Supplement Market: Technology Evolution, …
The global collagen supplement market is experiencing steady and sustained expansion as consumers increasingly prioritize preventive healthcare, functional nutrition, and beauty-from-within solutions. Collagen, long recognized for its role in skin elasticity, joint mobility, and bone strength, is now firmly positioned at the intersection of health, wellness, and cosmetic nutrition. In 2025, the market is valued at USD 1.8 billion and is forecast to reach USD 3.3 billion by 2035, expanding…
Japan Dried Spent Grain Market Deep-Dive 2026-2036: Strategic Forecasts, Market …
Japan's demand for dried spent grain is entering a phase of measured and dependable expansion, supported by steady brewing output, disciplined feed procurement, and gradual adoption in food manufacturing. Valued at USD 784.8 million in 2026, the market is projected to reach USD 1,109.4 million by 2036, registering a CAGR of 3.5% over the forecast period. Growth reflects consistent utilization rather than volatility, anchored in Japan's well-established food, beverage, and…
More Releases for Aureus
Rise In Prevalence Of Methicillin-Resistant Staphylococcus Aureus Infections: Po …
Use code ONLINE30 to get 30% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts.
What Is the Expected CAGR for the Methicillin-Resistant Staphylococcus Aureus (MRSA) Drugs Market Through 2025?
In recent times, the market size of drugs for methicillin-resistant staphylococcus aureus (MRSA) has seen continuous growth. The market, which was worth $2.35 billion in 2024, is projected to expand to $2.47 billion in…
Leading Growth Driver in the Methicillin-Resistant Staphylococcus Aureus (MRSA) …
What market dynamics are playing a key role in accelerating the growth of the methicillin-resistant staphylococcus aureus (mrsa) drugs market?
The growth of the methicillin-resistant Staphylococcus aureus drugs market is expected to be fuelled by the rise in Hospital Acquired Infections (HAIs). Patients acquire these infections while being treated at a healthcare center, usually 48 hours or more post admissions. The root causes behind HAIs include contaminated medical apparatus, lax hand…
Staphylococcus Aureus Testing Market In-Depth Market Research Report 2027
A wide range of human clinical infection caused by Staphylococcus Aureus such as Skin, soft tissue, bacteremia, infective endocarditis and others are the major infection caused by Staphylococcus Aureus. The increased use of Staphylococcus Aureus testing in the diagnosis of staph infection grow rapidly, due to the availability of the various advanced test to screen the pathogen efficiently. There is a number of tests present in the market for Staphylococcus…
Methicillin-resistant Staphylococcus Aureus Therapeutics Pipeline Analysis 2018
MRSA infection caused by specific "staph" bacteria that is often resistant to most of antibiotic treatments. S. aureus (SA) is listed as a ‘superbug’ by U.S. Centers for Disease Control and Prevention (CDC). MRSA can either be present harmlessly on the skin (colonization) or enter the body (e.g. through broken skin) and cause an infection. The study analyzed that MRSA infection therapeutics pipeline comprises approximately 52 drug candidates in different…
Methicillin-resistant Staphylococcus Aureus (MRSA) Drugs Market – Driver
Methicillin-Resistant Staphylococcus Aureus (MRSA) is a type of staphylococcus aureus, which became resistant to methicillin, amoxicillin, penicillin, oxacillin, and other such commonly used antibiotics. Staphylococcus aureus harbors on the skin and nasal passage of about one third of the world population, which comprises around 33%, as per Centers for Disease Control and Prevention (CDC) review 2015. MRSA can be classified into two types, based on mode of infection – Hospital…
Vancomycin Resistant Staphylococcus Aureus Infection (VRSA) Market : Evolving Te …
Global Vancomycin Resistant Staphylococcus Aureus Infection (VRSA) Market: Brief Description
Staphylococcus aureus is an anaerobic gram positive bacteria, commonly found in the respiratory tract of human and on the skin. This strain of bacteria is always not pathogenic but remains a major cause for respiratory diseases, skin infections and food poisoning. S.aureus strains often promote infections by producing harmful protein toxins. It is anticipated that approximately 20% of the population…
